March 26, 2012
Pharma Forum Institute and Japan Pharma Licensing Association (JPLA) Keiji Nakamura, Ph. D. Struggling Clinical Trials for AD Alzheimer disease (AD) is the most common form of dementia. There is no cure for the disease which worsens as it progresses...read more